Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Skin may slow repair by blocking and its repair signal

In adult human skin, may improve the while suppressing recognition of and the signal proposed to enable repeated repair. would reject this chain if repair stayed slow after confirmed restoration of the immune signal.

Stage of verification

  1. Hypothesis published2026-09-26
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionSkin

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Adaptive immune repair permission
Goal
Идентификация терапии с десятилетним восстановлением функций кожи
Competing hypotheses
2
Published
2026-09-26
As a hypothesis
8 / 10Clarity of mechanism
7 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
9 / 10Few new entities
8 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research
Poster: Skin lipids suppress repair signaling
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Immune cell

    -reactive

    that recognize and provide an immune signal involved in epidermal barrier repair

    Where this hypothesis actsHuman skin after repeated friction and drying under lamellar lipid treatment

    Hypotheses on this target 1
    CD1a-reactive T cellsActivation. Hypotheses on this target 11Clearance restoration. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Adoptive transfer. Hypotheses on this target 0Elimination. Hypotheses on this target 0Immunosuppression. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Activation1
    • Clearance restoration
    • Reprogramming
    • Adoptive transfer
    • Elimination
    • Immunosuppression
    • Population balance

    What is proposed

    Activation

    Briefly activate -reactive after mechanical stress

    With whatNot stated in the record

    HowShort activation of -reactive after stress; the activation technique is not stated

    Possible result

    Expected reversal of delayed barrier recovery

    From the recordКороткая активация аутологичных CD1a-реактивных Т-клеток после нагрузки должна устранить задержку

  2. Receptor or channel

    A lipid-binding molecule on recognized by

    Where this hypothesis acts in human skin exposed to lamellar formulations containing

    Hypotheses on this target 1
    CD1aLower level. Hypotheses on this target 0Higher level. Hypotheses on this target 0Blockade. Hypotheses on this target 11Agonism. Hypotheses on this target 0Desensitisation. Hypotheses on this target 0Function restoration. Hypotheses on this target 0Function preservation. Hypotheses on this target 0
    • Lower level
    • Higher level
    • Blockade1
    • Agonism
    • Desensitisation
    • Function restoration
    • Function preservation

    What is proposed

    Blockade

    Block recognition of to test its role in barrier recovery

    With whatSmall molecule

    How in the control group; matched lamellar formulations also vary in their ' ability to block recognition

    Possible result

    Expected reproduction of delayed barrier recovery

    From the recordБлокада CD1a в контрольной группе должна воспроизвести задержку.

  3. Signalling molecule

    An immune signalling molecule implicated in epidermal barrier recovery after microinjury

    Where this hypothesis actsHuman skin after stress and brief activation of -reactive

    Hypotheses on this target 1
    Interleukin-22Lower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Neutralisation. Hypotheses on this target 11Supplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0
    • Lower level
    • Synthesis suppression
    • Neutralisation1
    • Supplementation
    • Accelerated excretion

    What is proposed

    Neutralisation

    Block to test whether it mediates restored barrier recovery

    With whatNot stated in the record

    How after T-cell activation; the blocking agent is not stated

    Possible result

    Expected loss of the recovery restored by T-cell activation

    From the recordблокада интерлейкина-22 должна отменить это восстановление.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTInterleukin-22. Hypotheses on this target 1Interleukin-22
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKαCD1a. Hypotheses on this target 1CD1a
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin that holds water better between everyday stresses might still recover more slowly after repeated rubbing and drying. The unexpected move is to attribute that mismatch to treatment fats blocking , rather than to weakened connections between skin cells or chemical damage to those cells. This is a hypothesis generated by the pipeline, not a measured treatment effect.

The proposed mechanism, link by link
  1. The proposal begins with a layered fat treatment improving the skin's resting resistance to water loss.
  2. in some formulations are proposed to increase the share of -bound that inhibit .
  3. After minor damage, those bound are proposed to shift the immune response from a brief repair signal to a suppressed signal.
  4. Reduced T-cell activation is proposed to diminish the early pulse.
  5. Loss of that pulse is proposed to slow recovery after subsequent rubbing and drying, despite preserved .
  6. Briefly restoring the immune signal is predicted to restore recovery without requiring a change in immune-cell numbers or composition.
A picture for it

A building can have a better waterproof roof while its damage alarm is muffled. It stays dry in ordinary weather, but repairs after each storm start too slowly.

Where the picture breaks: The picture separates water protection from a repair signal, but skin has no single alarm or repair crew. Whether the proposed immune signal is necessary for recovery is precisely what remains unestablished.

  1. Master questionstep 01 of 04

    The aim is a treatment that brings the skin function of middle-aged people closer to that of young people.

    Rests on: The supplied goal explicitly makes youthful skin function the treatment target.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The treatment target adds a ten-year restoration criterion for skin function.

    Rests on: The master question supplies the comparison with younger skin, but no ten-year criterion.

    Assumption

    A ten-year criterion is taken as given. The supplied text does not clarify whether this means reversing a decade of functional decline or maintaining restored function for a decade.

  3. Gap questionstep 03 of 04

    , a treatment using fats arranged in layers, might reduce resting water loss while slowing recovery after repeated rubbing and drying, even when the layered fat structure has been restored.

    Rests on: The broader goal concerns restored skin function; this stage selects a possible conflict between holding water at rest and recovering after stress.

    Leap

    The preceding stage supplies no reason for selecting layered fat treatments or this particular conflict as the route to its ten-year target. The supplied sources do not establish that treatment-induced conflict.

  4. Hypothesisstep 04 of 04

    Some treatment fats are proposed to suppress a brief immune signal needed for repeated repair. The proposed route involves , cluster of differentiation 1a, a protein that holds for recognition by immune cells; , immune cells in the skin's outer living layer; and , immune cells that respond to the body's own molecular structures. The treatment is proposed to reduce their release of , an immune messenger, without requiring a change in immune-cell numbers or in which cell families are present.S3S4

    Rests on: The gap supplies the proposed mismatch between resting protection and recovery. S3, in Nature Immunology (2010), describes -dependent production in cell cultures, but does not establish that this signal is necessary for skin repair. S4, available here only as an abstract from The British Journal of Dermatology (2026), reports that processing inhibitory , a lipid with a long molecular tail, promoted -directed immune activity; it does not establish the proposed treatment effect or repair sequence.

    Supported by literature

What is carried, and what is not. Screened sources speak to two component relationships: lipid-dependent inhibition of recognition and -linked production of . S4's 2026 dermatology abstract addresses the first without testing treatment-induced repair delay, and S3's 2010 Nature Immunology cell-culture work addresses the second without showing repair necessity; neither establishes the sequence from applying a formulation to impaired recovery.S4S3

Where the reasoning is carried by something unstated · 2
  • Goal pillar. A ten-year criterion is taken as given. The supplied text does not clarify whether this means reversing a decade of functional decline or maintaining restored function for a decade.
  • Gap question. The preceding stage supplies no reason for selecting layered fat treatments or this particular conflict as the route to its ten-year target. The supplied sources do not establish that treatment-induced conflict. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • A formulation could suppress the immune signal and also cause chemical damage to skin cells; delayed recovery could then be credited entirely to immune suppression. Matching initial damage, hydration, and crack growth does not establish equal chemical damage. What closes it: The comparison must also assess , chemical reactions that damage fats, and associated cell damage across repeated stresses. The design does not specify those measurements, although oxidative damage is one of its stated rivals.
  • Failure of immune stimulation to restore recovery could mean that the proposed mechanism is wrong, or that the cultured skin no longer contains functioning cells capable of delivering the intended signal. What closes it: The experiment must verify functioning and same-donor through repeated stresses, and confirm restoration of the early signal before treating persistent delay as a refutation. The supplied design explicitly identifies cell preservation as a technical difficulty.
  • Reduced immune activation could be mistaken for evidence that inhibitory occupy when the intervention instead reduces the amount of available for recognition. S5, in Scientific Reports (2017), reports altered location and reduced presentation after pollutant exposure in human immune cells, but does not establish that a skin formulation acts this way.S5 What closes it: The proposed measurement of -bound lipid composition must be accompanied by measurement of availability at the cell surface. Otherwise, lipid occupancy and protein availability remain competing explanations for reduced recognition.

What would make this wrong. The supplied hypothesis identifies persistent repair delay after confirmed restoration of the brief immune signal as a refutation of its causal sequence, provided the initial damage, hydration, and crack growth remain comparable. The input does not define the named recovery indicator or specify a numerical threshold for successful restoration, so neither can be supplied here.

What it would change. If the mechanism held, improving skin function would require assessing recovery after repeated stress alongside resting water retention, because a formulation could improve one while impairing the other. Treatment composition would also need to preserve the proposed brief repair signal. Results in human skin maintained outside the body would still not establish rejuvenation in middle-aged people, the full range of youthful skin functions, or either interpretation of the ten-year target.

Sources read · 8

4 literature searches, 7 full texts, 3 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Group A Streptococcus induces CD1a-autoreactive T cells and promotes psoriatic inflammation. · Science immunology · 2023

“However, the presence of CD1a promoted the production of IL-22 and IFNγ from both CD4 + and CD8 + draining lymph node T cells after GAS infection ( ).”

Does not settle: Источник не устанавливает восстановление эпидермального барьера у взрослых людей, роль клеток Лангерганса при микроповреждении, действие ламеллярных составов или длинноцепочечных сфингомиелинов, потерю воды, повторные нагрузки либо SPV_1. Сообщение об интерлейкине-22 относится к модели инфекции стрептококком у CD1a-трансгенных мышей.

S2Partly answers it

Phospholipase activity of acyloxyacyl hydrolase induces IL-22-producing CD1a-autoreactive T cells in individuals with psoriasis. · European journal of immunology · 2022

“We found that the PLA 2 activity of rAOAH leads to the activation of circulating CD1a auto‐reactive T cells, leading to the production of IFN‐γ and IL‐22.”

Does not settle: Источник оставляет открытыми необходимость краткого сигнала CD1a-аутореактивных Т-клеток для повторного восстановления эпидермального барьера у взрослых людей, влияние ламеллярных составов и длинноцепочечных сфингомиелинов, связывание тормозящих липидов с CD1a, потерю воды, скорость восстановления после нагрузки, состав связанных с CD1a липидов и показатель SPV_1.

S3Partly answers it

CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. · Nature immunology · 2010

“CD1a dependent cytokine gene upregulation was measured by real-time PCR.”

Does not settle: Источник описывает CD1a-зависимую продукцию IL-22 в культурах Т-клеток и антигенпредставляющих клеток, но не устанавливает необходимость этого сигнала для восстановления эпидермального барьера у взрослых людей после микроповреждения. Он не проверяет ламеллярные составы, длинноцепочечные сфингомиелины, липиды, связанные с CD1a, потерю воды, повторные нагрузки, SPV_1 или независимость механизма от численности и клонального состава иммунных клеток.

S4Partly answers itAbstract only

CD1a-autoreactive T cell sensing of skin barrier compromise. · The British journal of dermatology · 2026

“Activated skin DCs expressed neutral sphingomyelinase, which processed inhibitory long chain sphingomyelin to drive Th2 cell CD1a-autoreactivity.”

Does not settle: Источник не устанавливает, что у взрослых людей повторное восстановление эпидермального барьера требует краткого сигнала аутореактивных Т-клеток или интерлейкина-22. В абстракте отсутствуют данные о ламеллярных составах, потере воды, скорости восстановления после последующих нагрузок, SPV_1 и независимости механизма от численности или клонального состава иммунных клеток.

S5Partly answers it

Inhibition of endocytic lipid antigen presentation by common lipophilic environmental pollutants. · Scientific reports · 2017

“These observations strongly support that the CD1a protein begins to be retained in recycling endosomes at the low BaP concentration and is further retained in early endosomes at the high concentration, suggesting the contribution of altered endocytic gene expression to the reduced lipid antigen presentation, lower CD1a expression, and inhibited T cell activation.”

Does not settle: Источник исследует воздействие бензо[a]пирена на человеческие дендритные клетки, а не ламеллярные составы, длинноцепочечные сфингомиелины, клетки Лангерганса или восстановление эпидермального барьера у взрослых людей. Он не устанавливает роль аутореактивных Т-клеток, интерлейкина-22, потери воды, замедления последующего восстановления, состава липидов, связанных с CD1a, или SPV_1.

S6Background

IgG regulates the CD1 expression profile and lipid antigen-presenting function in human dendritic cells via FcgammaRIIa. · Blood · 2008

“Finally, the ability of DCs to activate CD1-restricted NKT cells and T cells was determined by this regulatory effect of IgG.”

Does not settle: Источник описывает влияние IgG на профиль CD1 и активацию T-клеток in vitro в человеческих дендритных клетках. Он не устанавливает восстановление эпидермального барьера у взрослых людей, участие клеток Лангерганса, связывание сфингомиелинов с CD1a, интерлейкин-22, скорость восстановления после микроповреждения или SPV_1.

S7Background

The CD1 size problem: lipid antigens, ligands, and scaffolds. · Cellular and molecular life sciences : CMLS · 2014

“individual lipids can act as stimulatory antigens, inhibitory ligands, or space-filling scaffolds.”

Does not settle: This review abstract does not establish effects in adult human epidermis, Langerhans cells, autoreactive T cells, interleukin-22, barrier-repair kinetics, sphingomyelin formulations, or SPV_1.

S8BackgroundAbstract only

CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. · Journal of immunology (Baltimore, Md. : 1950) · 1999

“Here, we report two human CD8+ TCR alphabeta+ T cell lines specific for Mycobacterium tuberculosis Ags presented in the context of CD1a or CD1c Ag-presenting molecules.”

Does not settle: Источник описывает две линии человеческих CD8+ Т-клеток, распознающих липидные антигены Mycobacterium tuberculosis через CD1a или CD1c. Он не устанавливает роль аутореактивных Т-клеток, клеток Лангерганса, интерлейкина-22, сфингомиелинов, восстановления эпидермального барьера или SPV_1.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Can layered skin fats reduce resting water loss yet slow recovery after repeated rubbing and drying?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Может ли снижать потерю воды в покое и одновременно ухудшать восстановление после повторного трения и высушивания, даже при подтверждённом восстановлении ?

What this question is asking

The question concerns whether a skin treatment can improve water retention while making recovery from everyday wear slower. It asks whether delivering fats in layers to middle-aged human skin reduces water escaping at rest but worsens recovery after repeated rubbing and drying, compared with skin without that treatment. It specifically asks whether these effects could coexist even when the arrangement of fats in the skin has been confirmed as restored. The pipeline assumes that the proposed treatment already improves surface measurements and asks whether those improvements could conceal poorer recovery; the supplied sources do not establish that treatment-specific premise.

What the terms mean
Lamellar lipid therapy
A treatment described here as delivering skin fats in layers. 'Lamellar' means layered and 'lipid' means fat or a fat-like substance; the supplied material does not specify the formulation.
RL-3
The pipeline’s label for the proposed treatment. Its identity, composition and the meaning of the label are not supplied.
Resting water loss
Water escaping through the skin when it is not undergoing the rubbing or drying challenge. A lower value describes water retention at that time and does not, by definition, measure later recovery.
Skin barrier or permeability barrier
The skin’s ability to limit passage of substances, including outward passage of water. The question focuses on water retention and restoration of that function after disturbance.
Lipid organization
The arrangement of fats within the skin’s outer layer, including their formation into layers. 'Restored' requires a reference arrangement and a measurement criterion, neither of which is specified here.
Functional resilience and recovery
The ability to maintain function during disturbance and regain it afterward. These involve degrees and timescales rather than a single yes-or-no state; the pipeline supplies no numerical limits.
Epidermis and laboratory epidermal equivalents
The epidermis is the outer part of the skin. Laboratory equivalents are experimental models of it; S1 studies these models rather than treated middle-aged people.
Relative humidity
The amount of water vapour in air relative to what it could hold at the same temperature. S1 changes this environmental condition, which is different from the question’s repeated rubbing-and-drying exposure.
Occlusion and occlusive membrane
Occlusion means covering the skin to restrict exchange with its surroundings, including water escape. S2 uses a covering membrane; the supplied evidence does not establish that the proposed fat treatment acts like that membrane.
Tissue fluid
Fluid within body tissues. The pipeline invokes it as a possible explanation for misleading surface measurements, but the supplied sources do not establish that role.
Acetone
A solvent used in the mouse experiment described for S2. That exposure differs from the proposed everyday rubbing and drying.
Stratum corneum and keratin
The stratum corneum is the outermost skin layer, containing structural proteins called keratins and an arrangement of fats. S3 reports incomplete organization of these components despite wound closure.
Hairless mice, pigs and mammals
Mice and pigs are the animal systems used in S2 and S3. Both belong, with humans, to the broader group called mammals; that shared membership does not establish identical treatment responses.
Friction and mechanical stress
Friction is rubbing between surfaces; mechanical stress includes forces that deform or wear the skin. The question concerns function after repeated exposure, whereas the supplied S7 finding establishes increased water loss after disturbance.
Younger-skin range
The range of function in younger people proposed as the comparison target. The input supplies neither age boundaries nor measured reference values.
What the question takes for granted
Premise not found in what was read
Lamellar delivery of RL-3 improves surface indicators, while occlusion and tissue-fluid mechanisms allow those indicators to diverge from functional resilience.

The pipeline describes RL-3 as a treatment delivered in layers of fats and assumes that it improves measurements taken at the skin surface. It also proposes that covering the skin to restrict water escape, or changes in fluid within the tissue, could make those measurements look better without improving recovery from wear. That assumption supplies the proposed reason why apparent restoration might coexist with poorer performance.

The supplied search results do not establish an effect of RL-3 or identify its composition. S2 reports abnormal recovery under an occlusive membrane in animals, and S3 reports wound closure despite incomplete organization of outer-skin components; neither establishes the proposed treatment-specific mechanism or a role for tissue fluid. Confirmed restoration of is a condition in the question, not a treatment result demonstrated by these sources. This absence of supporting results does not establish that the premise is false.S2S3

The same question asked without the part nothing read establishes:

  • Does layered skin-fat treatment in middle-aged humans reduce resting water loss while slowing recovery after repeated rubbing and drying, compared with untreated skin?
  • When layered skin-fat treatment restores the arrangement of fats in middle-aged human skin, how does recovery after repeated rubbing and drying compare with untreated skin?
What turns on the answer
  • Less resting water loss, slower recovery If fat organization were also restored, the treatment would improve water retention at rest while leaving the skin slower to recover after disturbance. Resting water loss and fat arrangement would therefore be insufficient, by themselves, to establish recovery comparable to younger skin.
  • Less resting water loss, unchanged or faster recovery The improvement in water retention would occur without the proposed recovery penalty under the conditions assessed. Whether recovery reached the younger-skin range would still depend on that comparison, which the supplied material does not provide.
  • The combined effect is not established If reduced resting water loss or restored fat organization were absent, poorer recovery would not demonstrate the particular combination the question asks about. The treatment could have other effects, but they would not settle whether successful structural restoration conceals impaired recovery.
Why it matters

Fats in the skin’s outer layer help limit water escape, so their arrangement is relevant to its protective barrier, as described in S4. Rubbing can increase water loss, as reported in S7, making recovery after disturbance a separate concern from water retention at rest. If treatment lowered resting water loss while delaying recovery, that resting measurement alone could give a misleading impression of protection during repeated use. If recovery instead remained intact or improved, attributing harm to the treatment on the basis of indirect animal findings would also be misleading.

What is already established

RL-3 улучшает поверхностные показатели; узлы и допускают расхождение этих показателей с функциональной устойчивостью.

What would have to be true

Барьер и механическая функция сохраняют молодой диапазон после повторных нагрузок; скорость восстановления остаётся в заранее заданных пределах.

What is missing

Не проверено, может ли подтверждённая нормализация сопровождаться причинным ухудшением восстановления при повторной бытовой нагрузке.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Проверяемая гипотеза: повторное восстановление у взрослого человека требует короткого сигнала от , распознающих молекулу на . Некоторые , содержащие , одновременно восстанавливают и увеличивают связывание с . Это подавляет необходимый импульс -22 после микроповреждения. Поэтому потеря воды в покое снижается, а восстановление после следующих нагрузок замедляется при сохранённой . Носителем нарушения служит состав , связанных с ; изменение численности или иммунных клеток для этого механизма не требуется. Восстановление краткого иммунного сигнала должно стабилизировать SPV_1.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

В сравнивают с одинаковыми барьерными и механическими свойствами, но различной способностью их блокировать распознавание . Гипотеза предсказывает замедление восстановления только у состава, который повышает долю на и подавляет ранний . в должна воспроизвести задержку. Короткая после нагрузки должна устранить задержку; -22 должна отменить это восстановление. Исходная величина повреждения, , и рост микротрещин должны оставаться сопоставимыми. Сохранение задержки после подтверждённого восстановления иммунного сигнала опровергнет предложенную причинную цепь.

Would tell it apart from at least one rival. The prediction specifies comparative recovery outcomes, responses to interventions, and an explicit rejection condition. These are measurable without numerical thresholds. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Связывание с , и восстановление барьера можно исследовать в и . Главная техническая трудность состоит в сохранении функциональных и при повторных нагрузках. Иммунные вмешательства сначала проверяются вне организма. Результаты обычной недостаточны для проверки человеческой системы .

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

В сравнивают с одинаковыми барьерными и механическими свойствами, но различной способностью их блокировать распознавание . Гипотеза предсказывает замедление восстановления только у состава, который повышает долю на и подавляет ранний . в должна воспроизвести задержку. Короткая после нагрузки должна устранить задержку; -22 должна отменить это восстановление. Исходная величина повреждения, , и рост микротрещин должны оставаться сопоставимыми. Сохранение задержки после подтверждённого восстановления иммунного сигнала опровергнет предложенную причинную цепь.

  • What would separate them

    Lamellar lipid therapy may slow skin repair by weakening contacts between outer skin cells predicts: На изолированном человека после обработки и удаления остатков средства должны наблюдаться ускоренный рост и снижение числа циклов до потери герметичности. Эффект должен сохраняться без живого и иммунных клеток при одинаковых , температуре и измеренной механической нагрузке. Параметры, оценённые на одной серии нагрузок, должны предсказывать рост трещин на независимой серии с другой . В живой ткани задержка восстановления должна зависеть от накопленной длины трещин. Отсутствие дополнительного роста трещин при сохранённой задержке восстановления опровергнет эту гипотезу как основное объяснение.

  • What would separate them

    Oxidation of treatment lipids may damage skin cells and slow recovery after friction and drying predicts: В сравнивают исходный состав с вариантом, в котором окисляемая заменена с в . До нагрузки подтверждают сопоставимые , , потерю воды, , механические свойства и активность системы . Гипотеза предсказывает, что уменьшит образование и и устранит задержку восстановления при неизменном первоначальном механическом повреждении. Снижение без улучшения восстановления опровергнет их ведущую причинную роль. Возникновение эффекта только при сильном искусственном не подтвердит объяснение бытовой уязвимости.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В здоровой коже обнаружены -, способные выделять интерлейкин-22. Отдельно показано, что 42:2, в отличие от некоторых более коротких видов, резко подавляет взаимодействие с . Эти наблюдения допускают независимое изменение физического барьера и иммунного распознавания, но сами по себе не подтверждают предложенную задержку восстановления. [de Jong и соавторы, 2010](https://pmc.ncbi.nlm.nih.gov/articles/PMC3131223/); [Cotton и соавторы, 2021](https://pmc.ncbi.nlm.nih.gov/articles/PMC8111460/).

Subfield revised

. Пересмотра потребовала бы глава 124 «Skin Barrier and », особенно раздел о и восстановлении барьера: в последовательность восстановления пришлось бы включить обязательный даже при достаточном , нормальной и восстановленной . [Глава Prausnitz и соавторов](https://www.dermascope.com/wp-content/uploads/2014/03/Prausnitz-Derm-Book-Chapter-2012-693.pdf).

Testable surprise

Краткая полностью возвращает нормальную скорость восстановления после повторного трения, хотя дополнительное введение правильно организованных не помогает; специфическая делает ранее устойчивую кожу уязвимой без предшествующего нарушения .

Why this is not the mainstream account

В целевом поиске не найдено утверждения, что подавление ламеллярной терапией вызывает обязательный срыв повторного восстановления при нормальной . Общая связь с и возможность подавления уже описаны; новизна здесь ограничена утверждением об обязательности этого этапа и указанной причине терапевтического ухудшения. Отсутствие публикаций во всей литературе не доказано, поэтому статус предварительный.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.